Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer

Targeted therapy and immunotherapy have changed the treatment modes for advanced non-small cell lung cancer (NSCLC), moving from second-line to first-line treatment and significantly extending patients’ survival. Surgery and chemoradiotherapy remain the main treatment options for patients with local...

Descripción completa

Detalles Bibliográficos
Autores principales: Sa, Huanlan, Song, Peng, Ma, Kewei, Gao, Yong, Zhang, Li, Wang, Deqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781597/
https://www.ncbi.nlm.nih.gov/pubmed/31632066
http://dx.doi.org/10.2147/OTT.S222412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781597/
https://www.ncbi.nlm.nih.gov/pubmed/31632066
http://dx.doi.org/10.2147/OTT.S222412

Ejemplares similares